Quarterly ResultJul 30, 2026, 05:32 PM
Reliance Global Group H1 2026 Revenue Down 18.9%; Net Loss $3.46M
AI Summary
Reliance Global Group reported a revenue decrease of 18.9% to $5.94 million for the first half of 2026, with a net loss of $3.46 million, an improvement from the prior year. The company executed a 1-for-40 reverse stock split in May 2026 and significantly increased common shares outstanding through various offerings. Strategic investments were made in Enquantum and Innervate, and LifeSci Global Group LLC was formed.
Key Highlights
- H1 2026 revenue decreased by 18.9% to $5.94 million from $7.32 million in H1 2025.
- Net loss attributable to the company for H1 2026 was $3.46 million, an improvement from $4.45 million in H1 2025.
- Basic and diluted loss per share improved to $(6.93) in H1 2026 from $(61.20) in H1 2025.
- Executed a 1-for-40 reverse stock split on May 18, 2026.
- Total common shares outstanding increased to 820,948 as of June 30, 2026, from 266,103 as of Dec 31, 2025.
- Formed LifeSci Global Group LLC (LGG) and acquired a 34.24% equity interest in Enquantum for $834,000.
- Made an equity investment of $500,000 in Innervate Radiopharmaceuticals LLC.
- Working capital as of June 30, 2026, was approximately $1.23 million.
Price Impact
More from EZRA